Somerville Kurt F Novartis Ag Transaction History

Somerville Kurt F

  • $582 Million
  • Q2 2024

A detailed history of Somerville Kurt F transactions in Novartis Ag stock. As of the latest transaction made, Somerville Kurt F holds 31,225 shares of NVS stock, worth $3.64 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
31,225
Previous 53,484 41.62%
Holding current value
$3.64 Million
Previous $5.17 Million 35.74%
% of portfolio
0.57%
Previous 0.9%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$92.57 - $107.37 $2.06 Million - $2.39 Million
-22,259 Reduced 41.62%
31,225 $3.32 Million
Q1 2024

May 13, 2024
SELL
$95.27 - $108.47 $4.04 Million - $4.6 Million
-42,365 Reduced 44.2%
53,484 $5.17 Million
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $2.63 Million - $2.89 Million
-28,508 Reduced 22.92%
95,849 $9.68 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $435,094 - $482,862
-4,593 Reduced 3.56%
124,357 $12.7 Million
Q2 2023

Aug 11, 2023
SELL
$92.52 - $104.91 $1.43 Million - $1.62 Million
-15,440 Reduced 10.69%
128,950 $13 Million
Q1 2023

May 10, 2023
BUY
$80.03 - $92.81 $62,823 - $72,855
785 Added 0.55%
144,390 $13.3 Million
Q4 2022

Feb 09, 2023
SELL
$75.55 - $92.52 $777,787 - $952,493
-10,295 Reduced 6.69%
143,605 $13 Million
Q3 2022

Nov 08, 2022
SELL
$74.61 - $87.26 $86,174 - $100,785
-1,155 Reduced 0.74%
153,900 $11.7 Million
Q2 2022

Jul 19, 2022
SELL
$80.52 - $93.75 $519,917 - $605,343
-6,457 Reduced 4.0%
155,055 $13.1 Million
Q1 2022

May 17, 2022
SELL
$80.11 - $90.62 $1.05 Million - $1.19 Million
-13,140 Reduced 7.52%
161,512 $14.2 Million
Q4 2021

Feb 08, 2022
SELL
$79.7 - $88.13 $417,149 - $461,272
-5,234 Reduced 2.91%
174,652 $15.3 Million
Q3 2021

Nov 10, 2021
SELL
$81.78 - $95.14 $60,353 - $70,213
-738 Reduced 0.41%
179,886 $14.7 Million
Q2 2021

Aug 09, 2021
SELL
$85.24 - $94.15 $53,701 - $59,314
-630 Reduced 0.35%
180,624 $16.5 Million
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $181,195 - $213,679
2,170 Added 1.21%
181,254 $15.5 Million
Q4 2020

Feb 16, 2021
BUY
$78.07 - $94.43 $132,719 - $160,531
1,700 Added 0.96%
179,084 $16.9 Million
Q3 2020

Oct 28, 2020
BUY
$82.14 - $91.0 $68,011 - $75,348
828 Added 0.47%
177,384 $15.4 Million
Q2 2020

Jul 28, 2020
BUY
$80.93 - $91.1 $14,972 - $16,853
185 Added 0.1%
176,556 $15.4 Million
Q1 2020

May 07, 2020
BUY
$70.67 - $99.01 $285,153 - $399,505
4,035 Added 2.34%
176,371 $14.5 Million
Q4 2019

Jan 15, 2020
SELL
$84.35 - $95.37 $132,598 - $149,921
-1,572 Reduced 0.9%
172,336 $16.3 Million
Q3 2019

Nov 06, 2019
SELL
$85.54 - $94.26 $32,163 - $35,441
-376 Reduced 0.22%
173,908 $15.1 Million
Q2 2019

Jul 24, 2019
SELL
$75.4 - $92.8 $393,437 - $484,230
-5,218 Reduced 2.91%
174,284 $15.9 Million
Q1 2019

May 01, 2019
BUY
$75.32 - $86.15 $16,645 - $19,039
221 Added 0.12%
179,502 $17.3 Million
Q4 2018

Jan 24, 2019
BUY
$73.66 - $82.02 $72,186 - $80,379
980 Added 0.55%
179,281 $15.4 Million
Q3 2018

Oct 15, 2018
BUY
$66.94 - $77.43 $206,576 - $238,948
3,086 Added 1.76%
178,301 $15.4 Million
Q2 2018

Jul 30, 2018
BUY
$64.91 - $73.36 $121,641 - $137,476
1,874 Added 1.08%
175,215 $13.2 Million
Q1 2018

Apr 24, 2018
SELL
$70.39 - $84.15 $525,179 - $627,843
-7,461 Reduced 4.13%
173,341 $14 Million
Q4 2017

Feb 02, 2018
SELL
$72.33 - $77.64 $1.04 Million - $1.11 Million
-14,342 Reduced 7.35%
180,802 $15.2 Million
Q3 2017

Oct 26, 2017
BUY
$74.14 - $77.27 $14.5 Million - $15.1 Million
195,144
195,144 $16.8 Million

Others Institutions Holding NVS

# of Institutions
1,425
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $251B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Somerville Kurt F Portfolio

Follow Somerville Kurt F and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

News

Stay updated on Somerville Kurt F with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email